Suffering from a rare cancer, actress Emilie Dequenne reveals that she will “not live as long as expected”

Suffering from a rare cancer, actress Emilie Dequenne reveals that she will “not live as long as expected”
Suffering from a rare cancer, actress Emilie Dequenne reveals that she will “not live as long as expected”

Actress Émilie Dequenne confided Sunday evening on TF1 that she was fighting an increasingly aggressive cancer, which will mean that she will not live “not as long as expected”.

The 43-year-old Belgian revealed in October 2023 that she was suffering from cancer rarediagnosed two months earlier, and which has kept her away from film sets ever since.

“It turns out that, unfortunately, things are not progressing well. […] I'm off again for the chemo that I went through a little over a year ago.”she declared during an interview on the show 7 à 8. “Deep down, I know I won't live as long as I expected. […] I'm only 43 years old. I have always dreamed of living to be at least 80 years old and falling asleep permanently in my sleep. That's what I'm asking.”she said.

After following heavy treatment and experiencing remission for several months, the actress #ÉmilieDequenne must fight again against an aggressive cancer. She feels a vital need to talk about her fight. She is “The Portrait of the Week”, Sunday at 7:30 p.m., on @TF1. pic.twitter.com/Q1z8shWXlS

— Audrey Crespo-Mara (@audrey_crespo) https://twitter.com/audrey_crespo/status/1862607716604100952?ref_src=twsrc%5Etfw

“I trust medicine. […] I hope that research for my cancer will continue to advance.”explained the actress.

His cancer is a corticosurrénalomemalignant tumor of the adrenal gland, for which the prognosis is all the more dismal as this tumor is large.

Émilie Dequenne was revealed for her first role in “Rosetta”, by the Dardenne brothers, which won her the prize for best actress at the Film Festival in 1999.


-

-

PREV Dordogne: four young people between life and death after a serious road accident
NEXT living with HIV in France in 2024 remains a journey strewn with pitfalls